In performing due diligence, I discovered several of the stock exchange listed shroom startups are paying pump-n-dump “analysts” to promote psilocybin across speculator, investor, and general social media. Not coincidentally, their penny stocks valuations have seen a remarkable rise over the past couple of months. I expect that we’ll soon see the dump part of the pump.